Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI)

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 4, 2009, Pages 849-854

  Motosugi, Utaroh ^a   Ichikawa, Tomoaki ^a   Sou, Hironobu ^a   Sano, Katsuhiro ^a   Ichikawa, Shintaro ^a   Tominaga, Licht ^a   Araki, Tsutomu ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Arterial phase; Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid; Liver; MRI

Indexed keywords

GADOXETIC ACID; CONTRAST MEDIUM; GADOLINIUM ETHOXYBENZYL DTPA; GADOLINIUM PENTETATE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; ARTIFACT; CHRONIC LIVER DISEASE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DILUTION; FEMALE; HUMAN; IMAGE QUALITY; INJECTION; LIVER CELL CARCINOMA; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOLOGIST; COMPARATIVE STUDY; DOSE RESPONSE; IMAGE ENHANCEMENT; LIVER TUMOR; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ARTIFACTS; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SODIUM CHLORIDE;

EID: 70349669251     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21913     Document Type: Article

References (16)

1. Vogl TJ, Kummel S, Hammerstingl R, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67. (Pubitemid 26197732)
2. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008;18:457-467. (Pubitemid 351248177)
3. Lufkin RB, Pusey E, Stark DD, Brown R, Leikind B, Hanafee WN. Boundary artifact due to truncation errors in MR imaging. AJR Am J Roentgenol 1986;147:1283-1287. (Pubitemid 17185047)
4. Oshio K, Feinberg DA. GRASE (gradient- and spin-echo) imaging: a novel fast MRI technique. Magn Reson Med 1991;20:344-349.
5. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 2001;79:373-374.
6. Ichikawa T, Nakajima H, Nanbu A, Hori M, Araki T. Effect of injection rate of contrast material on CT of hepatocellular carcinoma. AJR Am J Roentgenol 2006;186:1413-1418. (Pubitemid 46112579)
7. Stadler A, Schima W, Ba-Ssalamah A, Kettenbach J, Eisenhuber E. Artifacts in body MR imaging: their appearance and how to eliminate them. Eur Radiol 2007;17:1242-1255. (Pubitemid 46691954)
8. Taber KH, Herrick RC, Weathers SW, Kumar AJ, Schomer DF, Hayman LA. Pitfalls and artifacts encountered in clinical MR imaging of the spine. Radiographics 1998;18:1499-1521. (Pubitemid 128467073)
9. Elster A, Burdette J. Questions and answers in magnetic resonance imaging. St. Louis: Mosby; 2001.
10. Erturk SM, Ichikawa T, Sou H, Tsukamoto T, Motosugi U, Araki T. Effect of duration of contrast material injection on peak enhancement times and values of the aorta, main portal vein, and liver at dynamic MDCT with the dose of contrast medium tailored to patient weight. Clin Radiol 2008;63:263-271. (Pubitemid 351215371)
11. Ichikawa T, Erturk SM, Araki T. Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material. Eur J Radiol 2006;58:165-176.
12. Awai K, Hori S. Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 2003;13:2155-2160. (Pubitemid 37080751)
13. Awai K, Hiraishi K, Hori S. Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. Radiology 2004;230:142-150. (Pubitemid 37549795)
14. Bae KT. Peak contrast enhancement in CT and MR angiography: when does it occur and why? Pharmacokinetic study in a porcine model. Radiology 2003;227:809-816.
15. Han JK, Kim AY, Lee KY, et al. Factors influencing vascular and hepatic enhancement at CT: experimental study on injection protocol using a canine model. J Comput Assist Tomogr 2000;24:400-406.
16. Han JK, Choi BI, Kim AY, et al. Contrast media in abdominal computed tomography: optimization of delivery methods. Korean J Radiol 2001;2:28-36.